Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGENUS INC Director's Dealing 2010

Apr 6, 2010

34023_dirs_2010-04-06_e6518350-8275-41e8-ba16-2b0b3bfae3b7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: ANTIGENICS INC /DE/ (AGEN)
CIK: 0001098972
Period of Report: 2010-03-22

Reporting Person: DECHAENE TOM (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-03-22 Stock Option, right to buy $14 E 17200 Disposed 2010-03-22 Common Stock (17200) Direct